Shenzhen Hepalink Pharmaceutical Co Ltd (002399) — Net Asset Momentum
Shenzhen Hepalink Pharmaceutical Co Ltd (002399) recorded a net asset momentum of -1.0% as of December 2025, with net assets of CN¥12.08 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Shenzhen Hepalink Pharmaceutical Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Shenzhen Hepalink Pharmaceutical Co Ltd Net Asset Momentum (2006–2025)
This chart tracks Shenzhen Hepalink Pharmaceutical Co Ltd's year-over-year net asset growth across 20 annual reporting periods from 2006 to 2025. The most recent momentum reading is -1.0%, with net assets of CN¥12.08 Billion CNY as of December 2025. Read Shenzhen Hepalink Pharmaceutical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Shenzhen Hepalink Pharmaceutical Co Ltd (2006–2025)
The table below shows the complete annual net asset history for Shenzhen Hepalink Pharmaceutical Co Ltd from 2006 to 2025, covering 20 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Shenzhen Hepalink Pharmaceutical Co Ltd (002399) total market value.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥12.08 Billion | CN¥16.63 Billion | CN¥4.55 Billion | ▼ -1.0% |
| 2024 | CN¥12.20 Billion | CN¥17.34 Billion | CN¥5.14 Billion | ▲ +1.8% |
| 2023 | CN¥11.99 Billion | CN¥19.20 Billion | CN¥7.22 Billion | ▼ -3.4% |
| 2022 | CN¥12.41 Billion | CN¥20.81 Billion | CN¥8.41 Billion | ▲ +7.7% |
| 2021 | CN¥11.52 Billion | CN¥19.11 Billion | CN¥7.58 Billion | ▼ -1.4% |
| 2020 | CN¥11.69 Billion | CN¥19.03 Billion | CN¥7.34 Billion | ▲ +56.5% |
| 2019 | CN¥7.47 Billion | CN¥15.24 Billion | CN¥7.77 Billion | ▲ +19.6% |
| 2018 | CN¥6.24 Billion | CN¥13.66 Billion | CN¥7.41 Billion | ▼ -18.8% |
| 2017 | CN¥7.69 Billion | CN¥13.19 Billion | CN¥5.50 Billion | ▼ -5.0% |
| 2016 | CN¥8.09 Billion | CN¥12.91 Billion | CN¥4.83 Billion | ▼ -8.0% |
| 2015 | CN¥8.79 Billion | CN¥12.17 Billion | CN¥3.38 Billion | ▲ +5.3% |
| 2014 | CN¥8.35 Billion | CN¥9.93 Billion | CN¥1.58 Billion | ▲ +3.5% |
| 2013 | CN¥8.07 Billion | CN¥8.27 Billion | CN¥203.80 Million | ▲ +0.3% |
| 2012 | CN¥8.05 Billion | CN¥8.26 Billion | CN¥214.53 Million | ▲ +1.7% |
| 2011 | CN¥7.91 Billion | CN¥7.97 Billion | CN¥59.98 Million | ▼ -1.4% |
| 2010 | CN¥8.02 Billion | CN¥8.13 Billion | CN¥103.44 Million | ▲ +649.7% |
| 2009 | CN¥1.07 Billion | CN¥1.38 Billion | CN¥306.33 Million | ▲ +247.7% |
| 2008 | CN¥307.83 Million | CN¥578.92 Million | CN¥271.09 Million | ▲ +110.2% |
| 2007 | CN¥146.44 Million | CN¥257.73 Million | CN¥111.28 Million | ▲ +60.3% |
| 2006 | CN¥91.33 Million | CN¥349.01 Million | CN¥257.68 Million | — |